Please login to the form below

Not currently logged in

Lundbeck launches Chorea Matters online resource

Includes recognising chorea education programme

Chorea Matters Lundbeck

Danish pharma company Lundbeck has launched an online resource for US Huntington's disease (HD) patients who suffer from chorea.

The company, whose products target HD and other brain disorders, has designed Chorea Matters to be used by both patients living with the condition and their carers.

The resource includes:

  • Information to help visitors better understand the HD chorea
  • A recognising chorea checklist
  • Recipes developed with HD patients in mind
  • Help finding support and getting involved with the HD community
  • Education material.

In addition, the website also has a number of videos that cover advice about recognising symptoms and discussing the condition with physicians, as well as patients' and carers' stories about living with the chorea.

The website links to Lundbeck's Moving Together for HD Facebook page, which was set up in April 2011 and features discussions around research, events and community events relating to HD.

16th January 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...